140 related articles for article (PubMed ID: 16728689)
1. Impaired inhibitory effect of interleukin-10 on the balance between matrix metalloproteinase-9 and its inhibitor in mononuclear cells from hyperhomocysteinemic subjects.
Holven KB; Halvorsen B; Bjerkeli V; Damås JK; Retterstøl K; Mørkrid L; Ose L; Aukrust P; Nenseter MS
Stroke; 2006 Jul; 37(7):1731-6. PubMed ID: 16728689
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum MMP-9/TIMP-1 ratio in patients with homozygous familial hypercholesterolemia: effects of LDL-apheresis.
Nenseter MS; Narverud I; Græsdal A; Bogsrud MP; Halvorsen B; Ose L; Aukrust P; Holven KB
Cytokine; 2013 Jan; 61(1):194-8. PubMed ID: 23131422
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated RANK ligand/RANK axis in hyperhomocysteinemic subjects: effect of treatment with B-vitamins.
Nenseter MS; Ueland T; Retterstøl K; Strøm E; Mørkrid L; Landaas S; Ose L; Aukrust P; Holven KB
Stroke; 2009 Jan; 40(1):241-7. PubMed ID: 19008470
[TBL] [Abstract][Full Text] [Related]
4. IL-18 initiates release of matrix metalloproteinase-9 from peripheral blood mononuclear cells without affecting tissue inhibitor of matrix metalloproteinases-1: suppression by TNF alpha blockage and modulation by IL-10.
Nold M; Goede A; Eberhardt W; Pfeilschifter J; Mühl H
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):68-75. PubMed ID: 12616343
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinase-9 in mononuclear cells of hyperhomocysteinaemic subjects.
Holven KB; Halvorsen B; Schulz H; Aukrust P; Ose L; Nenseter MS
Eur J Clin Invest; 2003 Jul; 33(7):555-60. PubMed ID: 12814391
[TBL] [Abstract][Full Text] [Related]
6. Transcription activity of MMP-2 and MMP-9 metalloproteinase genes and their tissue inhibitor (TIMP-2) in acute coronary syndrome patients.
Dabek J; Glogowska-Ligus J; Szadorska B
J Postgrad Med; 2013; 59(2):115-20. PubMed ID: 23793312
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages.
Kumada M; Kihara S; Ouchi N; Kobayashi H; Okamoto Y; Ohashi K; Maeda K; Nagaretani H; Kishida K; Maeda N; Nagasawa A; Funahashi T; Matsuzawa Y
Circulation; 2004 May; 109(17):2046-9. PubMed ID: 15096450
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of C-reactive protein and interleukin-6 in hyperhomocysteinemic subjects.
Holven KB; Aukrust P; Retterstol K; Hagve TA; Mørkrid L; Ose L; Nenseter MS
Scand J Clin Lab Invest; 2006; 66(1):45-54. PubMed ID: 16464786
[TBL] [Abstract][Full Text] [Related]
9. Oncostatin M, an interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells.
Nagata T; Kai H; Shibata R; Koga M; Yoshimura A; Imaizumi T
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):588-93. PubMed ID: 12615664
[TBL] [Abstract][Full Text] [Related]
10. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
11. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios.
Pérez P; Kwon YJ; Alliende C; Leyton L; Aguilera S; Molina C; Labra C; Julio M; Leyton C; González MJ
Arthritis Rheum; 2005 Sep; 52(9):2751-60. PubMed ID: 16142742
[TBL] [Abstract][Full Text] [Related]
12. [Effects of Bushen qiangdu decoction on MMP-9 and TIMP-1 produced by peripheral blood mononuclear cells in patients with ankylosing spondylitis].
Zhang YZ; Yan XP; Ye LY; Zhang WJ; Lou JN
Zhongguo Gu Shang; 2011 May; 24(5):387-91. PubMed ID: 21688534
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
[TBL] [Abstract][Full Text] [Related]
14. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 15 stimulates production of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by human peripheral blood mononuclear cells.
Constantinescu CS; Grygar C; Kappos L; Leppert D
Cytokine; 2001 Feb; 13(4):244-7. PubMed ID: 11237433
[TBL] [Abstract][Full Text] [Related]
16. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.
Tayebjee MH; Lip GY; Tan KT; Patel JV; Hughes EA; MacFadyen RJ
Am J Cardiol; 2005 Aug; 96(3):339-45. PubMed ID: 16054454
[TBL] [Abstract][Full Text] [Related]
17. Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency.
Saito S; Trovato MJ; You R; Lal BK; Fasehun F; Padberg FT; Hobson RW; Durán WN; Pappas PJ
J Vasc Surg; 2001 Nov; 34(5):930-8. PubMed ID: 11700497
[TBL] [Abstract][Full Text] [Related]
18. Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 as potential markers of carotid atherosclerosis in infraclinical hyperlipidemia.
Beaudeux JL; Giral P; Bruckert E; Bernard M; Foglietti MJ; Chapman MJ
Atherosclerosis; 2003 Jul; 169(1):139-46. PubMed ID: 12860260
[TBL] [Abstract][Full Text] [Related]
19. Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome.
Gonçalves FM; Jacob-Ferreira AL; Gomes VA; Casella-Filho A; Chagas AC; Marcaccini AM; Gerlach RF; Tanus-Santos JE
Clin Chim Acta; 2009 May; 403(1-2):173-7. PubMed ID: 19254704
[TBL] [Abstract][Full Text] [Related]
20. Protein tyrosine kinase and p38 MAP kinase pathways are involved in stimulation of matrix metalloproteinase-9 by TNF-alpha in human monocytes.
Nguyen J; Gogusev J; Knapnougel P; Bauvois B
Immunol Lett; 2006 Jul; 106(1):34-41. PubMed ID: 16720051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
